-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
GHkDSM5+pfMtAynSgCT33lp2M05rD06k/su60XrUBvoAUx83vEPySVu72ZThZBzN
cjvpYYlCwhQ9riQ18l09Jg==
SEC Form 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION 3. Transaction 4. Securities Acquired (A) or Disposed (D) Of 3,211,972 Boston Scientific Corporation - October 2002 Form 4 (continued) 4. Transaction 5. Number of Derivative 9. Number of 10. 11. Nature of Explanation of Responses :
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
Estimated average burden
hours per response. . . . . 0.5
or Trading Symbol
Number of Reporting
Person, if an entity
(voluntary)
(Month/Day/Year)
Date of Original
(Month/Year)
Filing (Check Applicable Line)
(Instr. 3)
(Month/Day/Year)
Code
and
Voluntary
Code
(Instr. 8)
(Instr. 3, 4, and 5)
Securities
Beneficially
Owned at
End ofMonth
(Instr. 3 and 4)
ship
Form:
Direct(D)
or
Indirect (I)
(Instr. 4)
Indirect
Beneficial
Ownership
(Instr. 4)
SEC 1474 (3-99)
(Instr. 3)
sion or
Exercise
Price of
Deri-
vative
Security
Date
(Month/
Day/
Year)
Code
and
Voluntary (V)
Code
(Instr.8)
Securities Acquired (A)
or Disposed (D) Of
(Instr. 3,4 and 5)
Expiration Date(ED)
(Month/Day/Year)
Underlying Securities
(Instr. 3 and 4)
of
Derivative
Security
(Instr.5)
Derivative
Securities
Beneficially
Owned
at End of
Month
(Instr.4)
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I)
Indirect
Beneficial
Ownership
(Instr.4)
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. |
Lawrence J. Knopf, Vice President ________________________________ 10-31-2002 ** Signature of Reporting Person Date Boston Scientific Corporation Page 2 SEC 1474 (3-99) |